Do some patients develop avascular necrosis after hip surgery?

Published Date: 16 Mar 2023

Avascular necrosis (AVN) is considered an iatrogenic complication after treatment for progressive hip dysplasia, but research in China has revealed two characteristics associated with this condition. ossification nuclei.

Read Full News

Latest News

One Shot or Two? What to Know About HPV Vaccination Recommendations

— Guidance is evolving

What's Behind Boy's Bullous Skin Lesions After Flu Symptoms?

Mycoplasma pneumonia identified as the culprit in this case of RIME

Meta's $17.1 Billion Settlement: A Chance for a Social Media Natural Experiment

Whether it advances the science depends on who can study the results

CDC, Epidemiologists Work on Definition for Measles Deaths

Standard workgroup process began over the summer

Navigating the Evolving Treatment Landscape in SMA: An Interactive Clinical Decision-Making Simulation

Navigating the Evolving Treatment Landscape in SMA: An Interactive Clinical Decision-Making Simulation

Navigating the Spectrum of SMA: From Genetic Insights to Timely Diagnosis

Navigating the Spectrum of SMA: From Genetic Insights to Timely Diagnosis

Todays Updates

Tailoring Pulmonary Rehab to Close the COPD Gap, With Omid Pourshahid, MD Omid Pourshahid, MD

At CHEST 2026, Pourshahid argued for matching patients to center-based, hybrid, or virtual pulmonary rehab based on a structured assessment.

Virtual Pulmonary Rehab and Matched Care, With Omid Pourshahid, MD Omid Pourshahid, MD

Omid Pourshahid, MD, MPH, discusses Medicare coverage for virtual pulmonary rehab and a matched-care pathway for center-based, hybrid, or virtual programs.

Experts Examine Biologic Coverage in Asthma and COPD

Experts Examine Biologic Coverage in Asthma and COPD

Type 2 Phenotyping in Asthma and COPD: Clinical Forum Perspectives

Type 2 Phenotyping in Asthma and COPD: Clinical Forum Perspectives

Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD

Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD

Real-World Data Show Switch to Subcutaneous Ocrelizumab Well Tolerated Marco Meglio

Data from the real-world, CONFIDENCE study found switching from intravenous to subcutaneous ocrelizumab was well tolerated in patients with relapsing and primary progressive MS.

New Phase 2 Trial Evaluates Fenebrutinib Dosing in Children With Relapsing MS Louie Pasculli

The phase 2 FENerations1 study is an open-label, single-arm, small-scale study evaluating fenebrutinib dosing in 8 to 12 children and adolescents with relapsing MS.

Todays Updates

Tailoring Pulmonary Rehab to Close the COPD Gap, With Omid Pourshahid, MD Omid Pourshahid, MD

At CHEST 2026, Pourshahid argued for matching patients to center-based, hybrid, or virtual pulmonary rehab based on a structured assessment.

Virtual Pulmonary Rehab and Matched Care, With Omid Pourshahid, MD Omid Pourshahid, MD

Omid Pourshahid, MD, MPH, discusses Medicare coverage for virtual pulmonary rehab and a matched-care pathway for center-based, hybrid, or virtual programs.

Experts Examine Biologic Coverage in Asthma and COPD

Experts Examine Biologic Coverage in Asthma and COPD

Type 2 Phenotyping in Asthma and COPD: Clinical Forum Perspectives

Type 2 Phenotyping in Asthma and COPD: Clinical Forum Perspectives

Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD

Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD

Real-World Data Show Switch to Subcutaneous Ocrelizumab Well Tolerated Marco Meglio

Data from the real-world, CONFIDENCE study found switching from intravenous to subcutaneous ocrelizumab was well tolerated in patients with relapsing and primary progressive MS.

New Phase 2 Trial Evaluates Fenebrutinib Dosing in Children With Relapsing MS Louie Pasculli

The phase 2 FENerations1 study is an open-label, single-arm, small-scale study evaluating fenebrutinib dosing in 8 to 12 children and adolescents with relapsing MS.

Latest News

— Guidance is evolving

Mycoplasma pneumonia identified as the culprit in this case of RIME

Whether it advances the science depends on who can study the results

Standard workgroup process began over the summer

Navigating the Evolving Treatment Landscape in SMA: An Interactive Clinical Decision-Making Simulation

Navigating the Spectrum of SMA: From Genetic Insights to Timely Diagnosis

News All Time

Vax Beliefs of HHS Deputy Secretary Nominee Probed at Hearing

Chris Klomp praised the MMR vaccine, but Sen. Wyden said Klomp's answers "created confusion"

Inquiry Slams Hospital for Failure to Protect Babies After Nurse's Murder Conviction

Concerns were kept quiet as babies fell ill at hospital where Lucy Letby worked

Twins Conjoined at Head Separated; Brain-Eating Amoeba Source; Mercury-Laden Lotion

Health news and commentary gathered by MedPage Today staff

Where Does Medicine's Responsibility for Human Trafficking End?

Public health is political, but it doesn't have to be partisan, says Nicholas Peoples, MD

RFK Jr. Picks New USPSTF Members

Under Kennedy's scrutiny, the preventive services panel hasn't met in more than a year

Mysterious Stomach Rash Had Unusual Source

It stemmed from prolonged contact with a certain device

RFK Jr. Bolsters Vaccine Skepticism at Children's Health Defense Conference

"We have started to ask the questions that you ... have been asking for years," he said

Doc Running for Congress Calls RFK Jr. 'Dangerous and Incompetent'

Community health and vaccination rates are big issues for California pediatrician

Stuttering: New Consensus Statement Highlights Neurobiology

New consensus guideline frames stuttering as a neurobiological condition, emphasizing that physicians play a crucial role in diagnosis and ongoing management.

NHS Alliance Warns ADHD, Autism Costs Spiralling

NHS leaders say soaring ADHD and autism assessment costs are forcing service cuts and disrupting long-term planning.

Meta Settlement Falls Short on Teen Mental Health Protections, Whistleblower Says

(This August 27 story has been republished to add an image, with no changes to text.)

A Camp for Children With Brain Injuries Zips Ahead

A Pennsylvania camp gives children and young adults with brain injuries a place to connect, but federal funding for traumatic brain injury programs remains uncertain.

Gabapentin Not Linked to Better Outcomes for Kids’ Migraine

For children hospitalized with migraine, gabapentin use wasn’t associated with less pain or fewer readmissions than no use in an observational study.

This 'Natural' Remedy Was Likely Culprit in Baby's Lead Poisoning

Clinicians should ask parents about all meds, traditional and complementary, expert advises

Are Suicide Attempts Contagious in Young People?

— "We know that suicidal behavior does not occur in a social vacuum," researcher says

Dravet Syndrome: Optimizing Early Diagnosis and Treatment Strategies

Dravet Syndrome: Optimizing Early Diagnosis and Treatment Strategies

Recommended News For You

Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.

Routine breast cancer screening can bring better outcomes for patients

Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy

Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer

Citing a cancer risk, the EPA sets a new limit on medical sterilization chemicals.

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

A new FDA boxed warning; suicides rocking college campuses; more people getting flu shots than COVID vaccines.

Recommended Articles For You

Practical Breakthroughs in Oncology Across Clinical Settings 

Immuno-Oncology in Daily Practice: Transforming Cancer Care One Patient at a Time 

Mechanisms of Tumor Cell Mechanical Adaptation During Invasion 

Unlocking the Benefits of Eltrombopag: A Comprehensive Guide 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL

2.

Which Salvage Therapy Is Best for Recurrent Prostate Cancer?

3.

Older Adults With Advanced Cancer Prioritize Quality of Life

4.

Researchers investigate risk of developing multiple primary cancers after surviving bowel cancer

5.

Novel Drug Cuts Risk for Death by 44% in Squamous Lung Cancer Trial

1.

Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms

2.

Case Learning from Acquired Platelet Function Disorders

3.

Essential Updates in Hematology in Daily Practice

4.

Tazemetostat: A Promising New Treatment for Cancer

5.

Dormant Tumor Cell Biomarkers for Early Oncologic Surveillance

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Emerging Concepts in Hematology

2.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

3.

Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion

4.

Understanding Anemia and Its Common Causes

5.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot